Steven Coutre
Hematology · Palo Alto, CANPI 1073600441
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $77,363 of the $91,850 with a category attached, or 84.2%. 16 manufacturers reported payments, led by Janssen Global Services, LLC at 32.5% of the total. Reporting peaked in 2020 at $43,650 and has fallen 99.4% since, to $280 in 2025.
Across 78 payments — averaging $1177.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Global Services, LLC$30K
- AbbVie$15K
- Pharmacyclics LLC, An Abbvie Company$15K
- Johnson & Johnson$9K
- Genentech, Inc.$8K
- Astellas Pharma US Inc$4K
- plus $11K from 10 others
Across 347 payments — averaging $20,581 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$4.9M
- Acerta Pharma LLC$694K
- Janssen Research & Development, LLC$613K
- Pharmacyclics LLC, An Abbvie Company$589K
- Takeda Pharmaceuticals U.S.A., Inc.$215K
- Gilead$66K
- plus $67K from 3 others
What the payments were for
- Consulting fees$77,36384%
- Speaking & faculty fees$9,29210%
- Travel & lodging$4,0514%
- Food & beverage$1,1441%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Global Services, LLC | 23 | $29,833 |
| AbbVie | 14 | $14,910 |
| Pharmacyclics LLC, An Abbvie Company | 9 | $14,881 |
| Johnson & Johnson | 11 | $9,477 |
| Genentech, Inc. | 7 | $7,710 |
| Astellas Pharma US Inc | 1 | $3,650 |
| Merck | 1 | $2,000 |
| Beigene USA, Inc. | 1 | $1,950 |
| AstraZeneca | 1 | $1,713 |
| Adaptive Biotechnologies Corporation | 2 | $1,533 |
| Janssen Scientific Affairs, LLC | 1 | $1,515 |
| Beigene, Ltd. | 1 | $1,300 |
| Acerta Pharma LLC | 1 | $900 |
| Taiho Oncology, Inc. | 2 | $280 |
| Novartis | 2 | $185 |
| Genentech USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$91,850 in reported general payments places this provider in the 80th percentile of 178 hematology providers in California.
Other hematology in Palo Alto
- Bita FakhriPalo Alto$171K
- Jason GotlibPalo Alto$63K
- Everett MeyerStanford$2.1M
- Doris QuonLos Angeles$1.5M
- Amrita KrishnanDuarte$671K
- Ilene WeitzLos Angeles$631K
- Vinod PullarkatDuarte$576K
- Hope RugoSan Francisco$537K
- Alexey DanilovDuarte$407K
- Caroline PiatekLos Angeles$391K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.